Japan Active Pharmaceutical Ingredients (API) Market Expected to Reach USD 43.2 Billion by 2033 - IMARC Group

January 16, 2025 | Healthcare

VIEW FULL TABLE OF CONTENTS

Japan Active Pharmaceutical Ingredients (API) Market Statistics, Outlook and Regional Analysis 2025-2033

The Japan active pharmaceutical ingredients (API) market size was valued at USD 27.9 Billion in 2024, and it is expected to reach USD 43.2 Billion by 2033, exhibiting a growth rate (CAGR) of 5% from 2025 to 2033.

Japan Active Pharmaceutical Ingredients (API) Market

To get more information on this market, Request Sample

The growing shift towards biopharmaceuticals is expanding the market growth in Japan. In December 2023, ACG Inc. invested approximately ¥50 Billion to expand its business of high-tech materials. Also, AGC planned to expand its CDMO services at its Yokohama Technical Center by adding new technologies to produce drugs from gene and cell therapies and mRNA pharmaceuticals by 2026.

Moreover, the API production landscape in Japan is rapidly digitalizing. Additionally, companies are using smart manufacturing technologies like machine learning, AI, the Internet of Things (IoT), etc., to improve production processes. These innovations increase operating efficiency, lower costs, and ensure adherence to tight regulatory requirements. In August 2024, NVIDIA introduced NVIDIA NIM microservices to facilitate the building of high-performance generative AI applications. Notable models include Llama-3-Swallow-70B for Japanese, which is intended to provide a better grasp of regional customs. In addition, predictive analytics and real-time monitoring improve quality control, reduce manufacturing errors, ensure API standards, etc. Besides this, the growing environmental concerns and regulatory challenges are pushing API manufacturers in Japan to prioritize sustainability. The implementation of green chemistry principles and environmentally friendly industrial methods is gaining traction. In March 2024, Lummus Technology and Sumitomo Chemical formed an alliance to commercialize Sumitomo's rPMMA recycling and LDPE/EVA production technologies.

Japan Active Pharmaceutical Ingredients (API) Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include Kanto region, Kansai/Kinki region, Central/Chubu region, Kyushu-Okinawa region, Tohoku region, Chugoku region, Hokkaido region, and Shikoku region. Extensive R&D initiatives undertaken by key industry players to improve the pharmaceutical industry are positively influencing the growth of the market.

Kanto Region Active Pharmaceutical Ingredients (API) Market Trends:

The strong presence of various pharmaceutical companies across the Kanto region is augmenting the market. Additionally, its robust infrastructure and proximity to international markets make it a vital location for API manufacturing, especially for novel drugs. Also, various companies across the region, like Takeda, focus on developing high-value APIs for cancer treatments.

Kansai/Kinki Region Active Pharmaceutical Ingredients (API) Market Trends:

The growing focus on biopharmaceutical APIs across the Kansai region is acting as one of the major growth-inducing factors. Moreover, there has been a significant traction of pharma giants across this region like Shionogi in Osaka. Besides this, the elevating demand for regenerative medicines in Kyoto is accelerating the market growth.

Central/Chubu Region Active Pharmaceutical Ingredients (API) Market Trends:

The region, which includes Nagoya, prioritizes sustainable API production. Moreover, companies such as Chubu Chemicals use green chemistry concepts to reduce the environmental effects during API production. Besides this, the region is home to various active pharmaceutical ingredients manufacturers who specialize in generic counterparts.

Kyushu-Okinawa Region Active Pharmaceutical Ingredients (API) Market Trends:

The increasing shift towards natural product-based medicines across the Kyushu-Okinawa region due to its rich biodiversity is positively influencing the market growth. The unique flora in Okinawa can be used to develop plant-based APIs. Moreover, various key companies in Fukuoka and Kumamoto focus on extracting and synthesizing APIs from marine and plant sources.

Tohoku Region Active Pharmaceutical Ingredients (API) Market Trends:

The expanding biopharmaceutical APIs in Sendai are supporting the market growth in the Tohoku region. Additionally, Tohoku University has been at the forefront of this transformation, thereby driving innovation in areas like APIs for regenerative medicine and advanced therapies. Local companies are also teaming up with international partners to develop APIs for cell and gene therapies, further escalating the market growth in the Tohoku region.

Chugoku Region Active Pharmaceutical Ingredients (API) Market Trends:

The increasing demand for over-the-counter products is propelling the market growth. Pharmaceutical companies in Hiroshima develop APIs for common colds and allergies. Also, Okayama's chemical industry provides high-quality intermediates for these APIs, ensuring consistent supply.

Hokkaido Region Active Pharmaceutical Ingredients (API) Market Trends:

Hokkaido, with its abundant natural resources, specializes in fermentation-based API production. Moreover, various companies like Meiji Seika Pharma use the region's agricultural resources to create APIs for antibiotics and enzymes. Besides this, Sapporo's research institutions promote fermentation technology innovation, further stimulating the growth of the market.

Shikoku Region Active Pharmaceutical Ingredients (API) Market Trends:

The surging development of cardiovascular medications in Tokushima is stimulating the growth of the market in the Shikoku region. The region's smaller-scale companies offer greater flexibility and customization in API development, addressing unique client requirements.

Top Companies Leading in the Japan Active Pharmaceutical Ingredients (API) Industry

The competitive landscape of Japan's active pharmaceutical ingredients (API) market is marked by prominent organizations that dominate the region. Companies that prioritize innovation and make significant investments in R&D activities emerge, producing high-quality specialty APIs for the highly complicated fields of oncology, cardiology, and diabetes. Strategic partnerships, joint ventures, and mergers are widespread as companies attempt to increase production capacity and market reach.

Japan Active Pharmaceutical Ingredients (API) Market Segmentation Coverage

On the basis of the drug type, the market has been bifurcated into innovative active pharmaceutical ingredients (API) and generic active pharmaceutical ingredients (API). Innovative active pharmaceutical ingredients (API) are designed to address specific medical needs, often targeting conditions that currently have limited or ineffective treatments. Moreover, generic active pharmaceutical ingredients (API) are chemically identical to those in branded medications but are produced after the original drug's patent expires.
On the basis of the type of manufacturer, the market has been bifurcated into captive manufacturers and merchant API manufacturers (innovative merchant API manufacturers and generic merchant API manufacturers). Captive manufacturers make APIs for their parent corporations, maintaining a consistent supply chain. Furthermore, merchant API manufacturers provide APIs to a variety of pharmaceutical companies, including generics producers, supporting the segment's growth.
On the basis of the type of synthesis, the market has been bifurcated into synthetic active pharmaceutical ingredients (API) (type (innovative synthetic APIs and generic synthetic APIs)), biotech active pharmaceutical ingredients (API) (type, (innovative biotech APIs and biosimilars), product (monoclonal antibodies, vaccines, cytokines, fusion proteins, therapeutic enzymes, and blood factors), and expression system (mammalian expression systems, microbial expression systems, yeast expression systems, transgenic animal systems, and others)). Among these, synthetic APIs dominate this segment in Japan because they are widely used in traditional small-molecule pharmaceuticals. They are created using chemical synthesis, which provides cost-effectiveness and scalability for bulk production.
Based on the therapeutic application, the market has been bifurcated into oncology, cardiovascular and respiratory, diabetes, central nervous system disorders, neurological disorders, and others. Oncology is one of the most important therapeutic applications driving the market, owing to rising cancer rates. Furthermore, because of Japan's aging population and lifestyle-related disorders, cardiovascular and respiratory diseases are among the most common therapy categories, driving the segment’s growth. Furthermore, as the prevalence of diabetes in Japan rises, the demand for APIs used in anti-diabetic therapy is also growing.

Report Features	Details
Market Size in 2024	USD 27.9 Billion
Market Forecast in 2033	USD 43.2 Billion
Market Growth Rate 2025-2033	5%
Units	Billion USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment: Drug Type Type of Manufacturer Type of Synthesis Therapeutic Application Region
Drug Types Covered	Innovative Active Pharmaceutical Ingredients (API), Generic Active Pharmaceutical Ingredients (API)
Types of Manufacturer Covered	Captive Manufacturers Merchant API Manufacturers: Innovative Merchant API Manufacturers, Generic Merchant API Manufacturers
Types of Synthesis Covered	Synthetic Active Pharmaceutical Ingredients (API): Type Biotech Active Pharmaceutical Ingredients (API): Type, Product, Expression System
Therapeutic Applications Covered	Oncology, Cardiovascular and Respiratory, Diabetes, Central Nervous System Disorders, Neurological Disorders, Others
Regions Covered	Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Browse IMARC Related Reports on Active Pharmaceutical Ingredients (API) Market:

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Japan Active Pharmaceutical Ingredients (API) Market Expected to Reach USD 43.2 Billion by 2033 - IMARC Group

Purchase Options New Year Sale

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.